SP 15D2

SPECIAL FINANCIAL REPORT

Company: Matinas BioPharma Holdings, Inc.
Filed: April 11, 2014
Period of Report: December 31, 2013
Accession Number: 0001144204-14-022099

View Document ↗ View on SEC.gov ↗